It seems that the haunting memories of the last H1N1 pandemic in 2009-2010 forced the WHO to take anticipated steps to escalate stock of vaccines in poor countries this time.
Even an independent review panel earlier this year had claimed that the WHO remains mismanaged when it comes to dealing with major pandemic.
Triggered by such allegations, the WHO announced that by 2015, the global production of seasonal flu vaccine is expected to double to 1.7 billion doses, lest there is no halt in the production in 11 new manufacturers under this project.
The United Nations agency claimed, “If a new influenza pandemic erupts, the world’s projected 37 vaccine makers could potentially triple their annual production of trivalent seasonal vaccine to make 5.4 billion doses of pandemic vaccine”.
WHO Assistant Director-General Marie-Paule Kieny told that this time the WHO has made sure that even if they are faced with any massive pandemic, not only the vaccine stock is adequate but the manufacturing sites are widely distributed to cater to the need of nations across the world.
It’s believed that influenza vaccine needs to be treated as a fair means of combating influenza pandemic instead of churning profit out of it.